BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 16082584)

  • 1. Effects of antisecretory agents on angiogenesis during healing of gastric ulcers.
    Akimoto M; Hashimoto H; Shigemoto M; Maeda A; Yamashita K
    J Gastroenterol; 2005 Jul; 40(7):685-9. PubMed ID: 16082584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of angiogenic factors and endothelin-1 in gastric ulcer healing.
    Akimoto M; Hashimoto H; Maeda A; Shigemoto M; Yamashita K
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():450S-454S. PubMed ID: 12193143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic ultrasonographic evaluation of gastric ulcer healing on treatment with proton pump inhibitors versus H2-receptor antagonists.
    Tanaka M; Maruoka A; Chijiiwa Y; Tanaka M; Nawata H
    Scand J Gastroenterol; 1994 Dec; 29(12):1140-4. PubMed ID: 7886404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastric mucosal levels of prostaglandins and leukotrienes in patients with gastric ulcer after treatment with rabeprazole in comparison to treatment with ranitidine.
    Okazaki M; Shimizu I; Ishikawa M; Fujiwara S; Yamamoto H; Shiraishi T; Horie T; Iuchi A; Ito S
    J Med Invest; 2007 Feb; 54(1-2):83-90. PubMed ID: 17380018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori infection delays healing of ischaemia-reperfusion induced gastric ulcerations: new animal model for studying pathogenesis and therapy of H. pylori infection.
    Konturek SJ; Brzozowski T; Konturek PC; Kwiecien S; Karczewska E; Drozdowicz D; Stachura J; Hahn EG
    Eur J Gastroenterol Hepatol; 2000 Dec; 12(12):1299-313. PubMed ID: 11192319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized controlled trial of rebamipide plus rabeprazole for the healing of artificial ulcers after endoscopic submucosal dissection.
    Fujiwara S; Morita Y; Toyonaga T; Kawakami F; Itoh T; Yoshida M; Kutsumi H; Azuma T
    J Gastroenterol; 2011 May; 46(5):595-602. PubMed ID: 21359522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphism of CYP2C19 and gastric emptying in patients with proton pump inhibitor-resistant gastric ulcers.
    Wada F; Murase K; Isomoto H; Soda H; Takeshima F; Omagari K; Mizuta Y; Tsukamoto K; Murata I; Kohno S
    J Int Med Res; 2002; 30(4):413-21. PubMed ID: 12235924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study on endoscopic ulcer healing of omeprazole versus rabeprazole with respect to CYP2C19 genotypic differences.
    Ando T; Kato H; Sugimoto N; Nagao Y; Seto N; Hongo H; Kajikawa H; Isozaki Y; Shimozawa M; Naito Y; Yoshida N; Ishizaki T; Yoshikawa T
    Dig Dis Sci; 2005 Sep; 50(9):1625-31. PubMed ID: 16133961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of active gastric ulcer--a European multicentre study. The European Rabeprazole Study Group.
    Dekkers CP; Beker JA; Thjodleifsson B; Gabryelewicz A; Bell NE; Humphries TJ
    Aliment Pharmacol Ther; 1998 Aug; 12(8):789-95. PubMed ID: 9726393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of rabeprazole once daily for acid-related disorders.
    Lanza F; Bardhan KD; Perdomo C; Niecestro R; Barth J
    Dig Dis Sci; 2001 Mar; 46(3):587-96. PubMed ID: 11318537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective healing of endoscopic submucosal dissection-induced ulcers by a single week of proton pump inhibitor treatment: a retrospective study.
    Kajiura S; Hosokawa A; Ueda A; Mihara H; Ando T; Fujinami H; Nishikawa J; Ogawa K; Minemura M; Sugiyama T
    BMC Res Notes; 2015 Apr; 8():150. PubMed ID: 25889379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endosonographic evaluation of the quality of ulcer healing induced by proton pump inhibitors.
    Tsukamoto Y; Goto H; Hase S; Niwa Y; Arisawa T; Hayakawa T; Yoshikane H
    J Clin Gastroenterol; 1995; 20 Suppl 2():S40-3. PubMed ID: 7594337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal concentration of basic fibroblast growth factor in the healing process in human giant gastric ulcers.
    Mizuki A; Tatemichi M; Nishiya H; Fukui K; Hayashi T; Tsukada N; Nagata H; Ishii H
    J Gastroenterol Hepatol; 2004 May; 19(5):528-34. PubMed ID: 15086596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The therapeutic effect of proton pump inhibitors on Helicobacter pylori-positive gastric ulcers.
    Sasakii M; Joh T; Yokoyama Y; Seno K; Tsuchida K; Kurokawa T; Itoh M
    J Pharm Pharmacol; 1999 Jul; 51(7):825-30. PubMed ID: 10467958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of melatonin and tryptophan on healing of gastric and duodenal ulcers with Helicobacter pylori infection in humans.
    Celinski K; Konturek PC; Konturek SJ; Slomka M; Cichoz-Lach H; Brzozowski T; Bielanski W
    J Physiol Pharmacol; 2011 Oct; 62(5):521-6. PubMed ID: 22204799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rabeprazole: a review of its use in acid-related gastrointestinal disorders.
    Langtry HD; Markham A
    Drugs; 1999 Oct; 58(4):725-42. PubMed ID: 10551440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials.
    Caro JJ; Salas M; Ward A
    Clin Ther; 2001 Jul; 23(7):998-1017. PubMed ID: 11519776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective randomized controlled trial to compare the effects of omeprazole and famotidine in preventing delayed bleeding and promoting ulcer healing after endoscopic submucosal dissection.
    Tomita T; Kim Y; Yamasaki T; Okugawa T; Kondo T; Toyoshima F; Sakurai J; Tanaka J; Morita T; Oshima T; Fukui H; Hori K; Watari J; Matsumoto T; Miwa H
    J Gastroenterol Hepatol; 2012 Sep; 27(9):1441-6. PubMed ID: 22497427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rabeprazole in treatment of acid peptic diseases: results of three placebo-controlled dose-response clinical trials in duodenal ulcer, gastric ulcer, and gastroesophageal reflux disease (GERD). The Rabeprazole Study Group.
    Cloud ML; Enas N; Humphries TJ; Bassion S
    Dig Dis Sci; 1998 May; 43(5):993-1000. PubMed ID: 9590413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of NC-1300-O-3 on healing of acetic acid-induced gastric ulcers in rats.
    Okabe S; Takagi K; Inoue K
    Jpn J Pharmacol; 1993 May; 62(1):25-33. PubMed ID: 8341026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.